James T. D’Olimpio, M.D., FACP, FAAHPM, is a nationally recognized physician executive, medical oncologist, researcher, educator, and healthcare strategist whose career has spanned more than four decades of transformative leadership in oncology, internal medicine, hospice and palliative care, clinical research, and healthcare operations. Throughout his distinguished career, Dr. D’Olimpio has remained committed to advancing patient-centered medicine while simultaneously helping healthcare organizations improve quality outcomes, physician collaboration, innovation, and long-term strategic growth. His professional journey reflects an uncommon balance of scientific rigor, compassionate leadership, academic excellence, and visionary thinking that has earned him respect across both clinical and executive healthcare communities.
Dr. D’Olimpio’s foundation in medicine began with his undergraduate studies in Biology at Boston University, followed by graduate-level special studies before earning his medical degree from the Autonomous University of Guadalajara. He later completed the prestigious Fifth Pathway Program at Mount Sinai School of Medicine, an experience that helped shape his disciplined and patient-focused approach to medicine. His postgraduate training included internship and residency work in internal medicine at Mount Sinai Hospital and Elmhurst Hospital Center, where he quickly distinguished himself through his leadership capabilities and clinical excellence, ultimately serving as Chief Resident. These early experiences created the framework for a lifelong career dedicated not only to treating disease but also to elevating the standards of care delivery within complex healthcare systems.
As his career progressed, Dr. D’Olimpio pursued specialized oncology training at Montefiore Medical Center and Albert Einstein College of Medicine, where he completed both clinical and research fellowships in oncology and cancer research. During this period, he developed a strong passion for supportive oncology, symptom management, and improving the quality of life for patients facing serious illnesses. Rather than focusing solely on disease treatment, he recognized the importance of treating the whole patient—physically, emotionally, psychologically, and spiritually. This philosophy would later become one of the defining pillars of his professional identity and leadership approach.
Over the course of his career, Dr. D’Olimpio became widely recognized for his expertise in oncology supportive care, palliative medicine, pain management, cancer cachexia, neuropathic pain, and symptom management. His leadership at Northwell Health’s Monter Cancer Center and North Shore University Hospital, where he served as Director of Supportive and Palliative Oncology, Pain, and Symptom Management for more than two decades, positioned him as one of the region’s foremost experts in integrated oncology care. In this role, he developed innovative multidisciplinary care programs designed to improve patient outcomes while enhancing communication and coordination among physicians, nurses, researchers, and healthcare administrators. His work helped redefine how supportive care services could be incorporated into comprehensive cancer treatment programs.
Dr. D’Olimpio’s influence extends well beyond clinical medicine into executive healthcare leadership and operational management. As Chief Medical Officer and Principal Investigator for Clinical Research Alliance, he has overseen clinical trial operations, medical governance, physician leadership initiatives, and research program development. His current role as Senior Clinical Research Consultant for RUA Diagnostics further demonstrates his ability to bridge clinical expertise with healthcare innovation, diagnostics advancement, and strategic advisory leadership. He has worked closely with healthcare systems, pharmaceutical sponsors, biologic therapeutic companies, and research organizations to help guide oncology-focused initiatives that improve both patient care and organizational effectiveness.
A highly accomplished researcher and published author, Dr. D’Olimpio has contributed extensively to medical literature, scientific abstracts, clinical studies, and educational publications over the course of his career. His research interests have focused heavily on palliative care, oncology supportive services, cancer-related cachexia, pain management, sickle cell disease, chemotherapy-induced side effects, and symptom control strategies. He has served as Principal Investigator or Co-Investigator on numerous Phase I, II, and III clinical trials involving breakthrough cancer therapies, nutritional interventions, pain treatment protocols, monoclonal antibodies, and supportive oncology innovations. His scholarly work has been presented through organizations such as ASCO, MASCC, AACR, and numerous peer-reviewed medical journals, further solidifying his reputation as a thought leader within the oncology and palliative care communities.
In addition to his clinical and research accomplishments, Dr. D’Olimpio has maintained a lifelong dedication to education and mentorship. As Assistant Professor of Medicine at both New York University School of Medicine and later the Zucker/Hofstra School of Medicine, he has mentored generations of medical students, oncology fellows, nurse practitioners, and healthcare professionals. He has delivered grand rounds presentations, keynote lectures, educational symposia, and national conference presentations throughout the United States and internationally. His teaching style is widely respected for combining scientific depth with empathy, communication, and practical clinical insight, helping shape the next generation of compassionate healthcare leaders.
Dr. D’Olimpio’s leadership has also extended into committee service, ethics oversight, curriculum development, and healthcare policy initiatives. Throughout his career, he has chaired and participated in numerous regional and system-wide committees involving cancer performance improvement, pain management, ethics, nutrition, medical education, palliative care, and hospital governance. His ability to collaborate across disciplines while maintaining a patient-first philosophy has made him a trusted advisor and respected voice among healthcare executives and physicians alike. His participation in organizations such as the American Society of Clinical Oncology, American Association for Cancer Research, American Academy of Hospice and Palliative Medicine, and the Multinational Association for Supportive Care in Cancer reflects his ongoing commitment to advancing medicine through collaboration and innovation.
Beyond medicine, Dr. D’Olimpio is known for his creativity, artistry, and appreciation for the humanities. An accomplished pianist with performances associated with Carnegie Hall, he has long believed that music, art, and compassion play a critical role in healing and human connection. His interests in painting, sketching, and music provide balance to an otherwise demanding professional life and reflect his belief that leadership must remain deeply connected to empathy, culture, and emotional intelligence. These creative passions have influenced his patient care philosophy, helping him foster meaningful relationships with patients, families, students, and colleagues throughout his career.
Throughout his distinguished journey, Dr. D’Olimpio has remained deeply committed to service, integrity, and the advancement of healthcare excellence. His work has consistently demonstrated an ability to combine high-level medical expertise with strategic organizational leadership and compassionate patient advocacy. Whether guiding oncology research initiatives, mentoring future physicians, leading supportive care programs, or advising healthcare organizations, he approaches every responsibility with humility, professionalism, and a clear sense of purpose. His unique combination of clinical insight, executive leadership, communication skills, and research expertise makes him exceptionally well-suited for board service and advisory leadership roles within healthcare, diagnostics, biotechnology, research, and innovation-focused organizations.
Today, Dr. D’Olimpio is actively seeking opportunities to contribute his decades of experience to forward-thinking organizations that value strategic healthcare leadership, patient-centered innovation, clinical excellence, and ethical governance. His extensive background in medicine, oncology, research, education, healthcare operations, and multidisciplinary leadership positions him as a uniquely qualified advisor capable of helping organizations navigate growth, innovation, and complex healthcare challenges. He remains passionate about improving lives, advancing medicine, and helping organizations achieve meaningful and measurable impact within the healthcare industry and beyond.
Character:
Dr. D’Olimpio exemplifies compassion, integrity, and unwavering dedication throughout every aspect of his professional career. His patient-first philosophy has consistently guided his leadership decisions and interactions with colleagues, students, and healthcare teams. He is widely respected for his humility, empathy, and commitment to improving quality of life for those facing serious illness and complex medical challenges.
Knowledge:
He possesses extraordinary depth of knowledge across oncology, internal medicine, palliative care, clinical research, and healthcare operations developed over more than forty years of medical leadership. His extensive academic, clinical, and research background allows him to provide valuable insight across both patient care and organizational strategy. Through his publications, presentations, clinical trials, and teaching appointments, he has continuously contributed to the advancement of medical science and physician education.
Strategic:
Dr. D’Olimpio has demonstrated exceptional strategic leadership in building supportive oncology programs, overseeing clinical research operations, and guiding multidisciplinary healthcare initiatives. His ability to align clinical excellence with operational efficiency has allowed organizations under his leadership to improve patient outcomes while strengthening institutional performance. He brings a visionary mindset to healthcare innovation and understands how to navigate complex challenges through collaboration, thoughtful planning, and long-term strategic thinking.
Communication:
A highly accomplished communicator known for translating complex medical concepts into meaningful and accessible discussions for patients, healthcare teams, executives, and public audiences. His national media appearances, keynote presentations, educational lectures, and mentorship roles reflect his ability to engage audiences with clarity, confidence, and authenticity. Whether speaking with patients, physicians, researchers, or board members, he communicates with professionalism, empathy, and credibility that inspires trust and collaboration.
